Journal Guide

The journal is devoted to the rapid publication of innovative preclinical investigations on therapeutic agents against cancer and pertinent findings of experimental and clinical oncology. In the journal you will find review articles, original articles, and short communications on all areas of cancer research, including but not limited to preclinical experimental therapeutics; anticancer drug development; cancer biochemistry; biotechnology; carcinogenesis; cancer cytogenetics; clinical oncology; cytokine biology; epidemiology; molecular biology; pathology; pharmacology; tumor cell biology; and experimental oncology. Papers concerning work on humans must comply with the principles of the declaration of Helsinki (1964). The approval of an ethical committee must then be stated on the manuscript. The editors reserve the right to reject a paper with questionable ethical justification.

The Official Journal of the International Isotope Society The Journal of Labelled Compounds and Radiopharmaceuticals publishes original scientific manuscripts dealing with all aspects of research in labelled compound preparation and application. This includes areas such as analytical control, self radiolysis, quality control handling, storage, and tracer methods used in chemical, biochemical, biological, pharmacological, medical, genetic, agricultural and geochemical research. All radionuclides and enriched stable nuclides are included. The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to the following fields: radionuclide production; cyclotron targetry; neutron irradiation methodology; precursor preparation and production; labelling synthesis (chemical, biochemical, radiation, isotope exchange, etc); automation of nuclide production, precursor, preparation and synthesis; analysis (methods, limitations, etc. for both radioactive and stable nuclides, including new detection techniques); radiopharmaceuticals; PET chemistry; quality control (an essential requirement for valid data and especially for radiopharmaceuticals); stability and storage problems; handling of Curie and multiCurie amounts of radioactivity; etc. JLCR Award for Young Scientists: The Journal of Labelled Compounds and Radiopharmaceuticals, in cooperation with the International Isotope Society Conferences and the International Conferences on Radiopharmaceutical Sciences, sponsor every year four Awards to early excellence in radiopharmaceutical research and isotope labelling.

J Mol Med publishes reports describing major advances in the understanding, prevention, diagnosis, and treatment of human disease through the application of molecular biology and gene technology, a research discipline that has become known as molecular medicine.  The journal publishes original papers and review articles of the highest quality pertinent to all aspects of human biology and pathophysiology. J Mol Med is the continuation of the Berliner Klinische Wochenschrift (1864), one of the oldest and most prestigious European journals in which great scientists such as Paul Ehrlich, Robert Koch and Otto Warburg published their seminal, epoch-making discoveries.

The official Journal of the European Peptide Society EPS The Journal of Peptide Science is a cooperative venture of John Wiley & Sons, Ltd and the European Peptide Society, undertaken for the advancement of international peptide science by the publication of original research results and reviews. The Journal of Peptide Science publishes three types of articles: Research Articles, Rapid Communications and Reviews. The scope of the Journal embraces the whole range of peptide chemistry and biology: the isolation, characterisation, synthesis properties (chemical, physical, conformational, pharmacological, endocrine and immunological) and applications of natural peptides; studies of their analogues, including peptidomimetics; peptide antibiotics and other peptide-derived complex natural products; peptide and peptide-related drug design and development; peptide materials and nanomaterials science; combinatorial peptide research; the chemical synthesis of proteins; and methodological advances in all these areas. The spectrum of interests is well illustrated by the published proceedings of the regular international Symposia of the European, American, Japanese, Australian, Chinese and Indian Peptide Societies. The Journal of Peptide Science publishes the bi-annual EPS Newsletter and sponsors the EPS Website http://www.eurpepsoc.com.

Journal of Pharmaceutical Analysis (JPA) is a peer-reviewed open access journal for original research articles, short communication as well as review articles related to all aspects of Pharmaceutical Analysis. JPA was launched in 2011, and published bimonthly by Xi'an Jiaotong University, with cooperation of the Chinese Pharmaceutical Association.Current areas of interest include, but are not limited to:• The new technique and method in Pharmaceutical Analysis• Analysis of traditional Chinese medicine (medicinal materials, patent medicine, prescription, injection)• Pharmaceutical analysis of complex system• Quality control and methods of biotech drug• Action mechanism and study their metabolisms in body• Quantitative and qualitative analysis in the drug screening process• Tracer analysis in molecular pharmacology• Quantitative analysis in biopharmaceutics• Clinical laboratory and bioanalysisAnalysis studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles), biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are also welcome.

The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI's goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science Product design Process design, optimization, automation and control Facilities; Information management Regulatory policy and strategy Supply chain developments Education and professional development Journal of Pharmaceutical Innovation publishes four issues a year.

This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focussing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants. Papers dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin. Bioanalytical papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology.In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.Audience: Analytical scientists, management in the pharmaceutical industry, clinical chemistry laboratories, academic institutions, government agencies, biochemists, microbiology specialists, pharmaceutical formulation scientists.

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Marine Drugs publishes reviews, regular research papers and short notes on the research, development and production of drugs from the sea. Our aim is to publish the experimental detail as much as possible, particularly synthetic procedures and characterization information for bioactive compounds. There is no restriction on the length of the experimental section.

Materials Advances is an international, gold open access journal, publishing high-quality research across the breadth of materials science. The journal accepts experimental or theoretical studies that report new understanding, applications, properties and synthesis of materials, building on and complementing the materials content already published across the Royal Society of Chemistry journal portfolio. Submissions are handled by our high profile associate editors, all of whom also look after submissions to Journal of Materials Chemistry A, B & C. The Materials Advances publishing experience comes with the reputation, standards, commitment and expertise you would expect from an RSC journal, plus the visibility boost that comes from being open access and part of the Journal of Materials Chemistry family.

Materials Chemistry Frontiers is devoted to the publication of original contributions at the interface of chemistry and materials science, with topics spanning but not limited to energy materials, catalysis, biomaterials, nanoscience, polymers, luminescent materials, and sensors. The journal places an emphasis on original research that demonstrates conceptual advancements with emerging applications, rather than primarily reporting technological improvements. Together with Organic Chemistry Frontiers and Inorganic Chemistry Frontiers, this suite of journals offers an authoritative portfolio that is jointly owned by the Chinese Chemical Society, the Royal Society of Chemistry, and partner institutions.

Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.

The journal publishes timely, critical reviews of topics related to medicinal research, broadly defined, to which the authors have made significant contributions. Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs. Reviews are mainly solicited by the editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Molecular Diversity presents refereed papers describing the development, application and theory of molecular diversity, and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full-length papers, perspectives, news and reviews. Coverage addresses the generation of molecular diversity, application of diversity for screening against alternative targets of all types, analysis of results and their application in various scientific disciplines. Topics include combinatorial chemistry and parallel synthesis; small molecule libraries; microwave synthesis; flow synthesis; fluorous synthesis; diversity oriented synthesis (DOS); nanoreactors; click chemistry; multiplex technologies; fragment- and ligand-based design; structure/function/SAR; computational chemistry and molecular design; chemoinformatics; screening techniques and screening interfaces; analytical and purification methods; robotics, automation and miniaturization; targeted libraries; display librar